BriaCell Therapeutics (BCTX) News
NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.06-0.105 (-3.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BCTX news summary
We found 3 recent headlines mentioning BriaCell Therapeutics (BCTX): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, BCTX is down 3.32% at $3.06. The most recent story, "Healthcare Stocks Advance: OBX Surges 38%, ONCO Gains 32%, TMDX Rises 26%", was published by Nasdaq on Nov 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BriaCell Therapeutics headlines
- Healthcare Stocks Advance: OBX Surges 38%, ONCO Gains 32%, TMDX Rises 26%(RTTNews) - Healthcare stocks moved higher following clinical, financial and corporate updates. Developments included positive melanoma therapy data, a reverse stock split, stronger quarterly…NasdaqBCTX, DAVI, OBX, ONCO
- BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026PHILADELPHIA and VANCOUVER, British Columbia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…GlobeNewswire
- BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast CancerPHILADELPHIA and VANCOUVER, British Columbia, Oct. 23, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…GlobeNewswire